Kara Scheibner

Hyaluronan Fragments Act as an Endogenous Danger Signal by Engaging TLR2

Kara Scheibner, Michael A. Lutz, Sada Boodoo et al. · The Journal of Immunology · 2006 · 698 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile

Kimberly Cramer-Morales, Margaret Nieborowska-Skorska, Kara Scheibner et al. · Blood · 2013 · 144 citations · Full text

Medicine, Cancer Biology, Oncology +16

2017 White Paper on Recent Issues in Bioanalysis: A Global Perspective on Immunogenicity Guidelines & Biomarker Assay Performance (Part 3 – Lba: Immunogenicity, Biomarkers and PK Assays)

Shalini Gupta, Susan Richards, Lakshmi Amaravadi et al. · Bioanalysis · 2017 · 67 citations · Full text

Pharmacy, Biomedical Sciences, Biopharmaceutics +16

c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase–Activated Leukemias

Nidal Muvarak, Shannon Kelley, Carine Robert et al. · Molecular Cancer Research · 2015 · 66 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

MiR-27a Functions as a Tumor Suppressor in Acute Leukemia by Regulating 14-3-3θ

Kara Scheibner, Brianne Teaboldt, Mary Claire Hauer et al. · PLoS ONE · 2012 · 62 citations · Full text

Life Sciences, Molecular Biology, Oncology +14